236 related articles for article (PubMed ID: 27634172)
1. An overview of chemical inhibitors of the Nrf2-ARE signaling pathway and their potential applications in cancer therapy.
Zhu J; Wang H; Chen F; Fu J; Xu Y; Hou Y; Kou HH; Zhai C; Nelson MB; Zhang Q; Andersen ME; Pi J
Free Radic Biol Med; 2016 Oct; 99():544-556. PubMed ID: 27634172
[TBL] [Abstract][Full Text] [Related]
2. HDAC inhibitors increase NRF2-signaling in tumour cells and blunt the efficacy of co-adminstered cytotoxic agents.
McMahon M; Campbell KH; MacLeod AK; McLaughlin LA; Henderson CJ; Wolf CR
PLoS One; 2014; 9(11):e114055. PubMed ID: 25427220
[TBL] [Abstract][Full Text] [Related]
3. NRF2 and the Hallmarks of Cancer.
Rojo de la Vega M; Chapman E; Zhang DD
Cancer Cell; 2018 Jul; 34(1):21-43. PubMed ID: 29731393
[TBL] [Abstract][Full Text] [Related]
4. Aldo-Keto Reductase Regulation by the Nrf2 System: Implications for Stress Response, Chemotherapy Drug Resistance, and Carcinogenesis.
Penning TM
Chem Res Toxicol; 2017 Jan; 30(1):162-176. PubMed ID: 27806574
[TBL] [Abstract][Full Text] [Related]
5. Controversy about pharmacological modulation of Nrf2 for cancer therapy.
Milkovic L; Zarkovic N; Saso L
Redox Biol; 2017 Aug; 12():727-732. PubMed ID: 28411557
[TBL] [Abstract][Full Text] [Related]
6. A Complementary Chemical and Genomic Screening Approach for Druggable Targets in the Nrf2 Pathway and Small Molecule Inhibitors to Overcome Cancer Cell Drug Resistance.
Matthews JH; Liang X; Paul VJ; Luesch H
ACS Chem Biol; 2018 May; 13(5):1189-1199. PubMed ID: 29565554
[TBL] [Abstract][Full Text] [Related]
7. The transcription factor NF-E2-related factor 2 (Nrf2): a protooncogene?
Shelton P; Jaiswal AK
FASEB J; 2013 Feb; 27(2):414-23. PubMed ID: 23109674
[TBL] [Abstract][Full Text] [Related]
8. The role of natural products in revealing NRF2 function.
Zhang DD; Chapman E
Nat Prod Rep; 2020 Jun; 37(6):797-826. PubMed ID: 32400766
[TBL] [Abstract][Full Text] [Related]
9. BET-ting on Nrf2: How Nrf2 Signaling can Influence the Therapeutic Activities of BET Protein Inhibitors.
Chatterjee N; Bohmann D
Bioessays; 2018 May; 40(5):e1800007. PubMed ID: 29603290
[TBL] [Abstract][Full Text] [Related]
10. The Good and Bad of Nrf2: An Update in Cancer and New Perspectives in COVID-19.
Emanuele S; Celesia A; D'Anneo A; Lauricella M; Carlisi D; De Blasio A; Giuliano M
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360732
[TBL] [Abstract][Full Text] [Related]
11. Targeting the NF-E2-related factor 2 pathway for overcoming leukemia.
Harifi-Mood MS; Daroudi M; Darroudi M; Naseri K; Samarghandian S; Farkhondeh T
Int J Biol Macromol; 2023 Dec; 253(Pt 8):127594. PubMed ID: 37890739
[TBL] [Abstract][Full Text] [Related]
12. The impact of mitochondria on cancer treatment resistance.
van der Merwe M; van Niekerk G; Fourie C; du Plessis M; Engelbrecht AM
Cell Oncol (Dordr); 2021 Oct; 44(5):983-995. PubMed ID: 34244972
[TBL] [Abstract][Full Text] [Related]
13. Nrf2 in cancer: An insufficiently explored and controversial research area.
Yang Z
Dig Liver Dis; 2023 Dec; 55(12):1774. PubMed ID: 37673767
[No Abstract] [Full Text] [Related]
14. Synergistic Effects of Tranylcypromine and NRF2 Inhibitor: A Repurposing Strategy for Effective Cancer Therapy.
Chen D; Chen S; Zhou F; Bo Chen L; Chen MW
ChemMedChem; 2023 Dec; 18(24):e202300282. PubMed ID: 37871186
[TBL] [Abstract][Full Text] [Related]
15. Exploring structural effects in a new class of NRF2 inhibitors.
Hou Z; Lockwood L; Zhang D; Occhiuto CJ; Mo L; Aldrich KE; Stoub HE; Gallo KA; Liby KT; Odom AL
RSC Med Chem; 2023 Jan; 14(1):74-84. PubMed ID: 36760735
[TBL] [Abstract][Full Text] [Related]
16. Nrf2 as a key player of redox regulation in cardiovascular diseases.
Barančík M; Grešová L; Barteková M; Dovinová I
Physiol Res; 2016 Sep; 65 Suppl 1():S1-S10. PubMed ID: 27643930
[TBL] [Abstract][Full Text] [Related]
17. Role of KEAP1/NRF2 and TP53 Mutations in Lung Squamous Cell Carcinoma Development and Radiation Resistance.
Jeong Y; Hoang NT; Lovejoy A; Stehr H; Newman AM; Gentles AJ; Kong W; Truong D; Martin S; Chaudhuri A; Heiser D; Zhou L; Say C; Carter JN; Hiniker SM; Loo BW; West RB; Beachy P; Alizadeh AA; Diehn M
Cancer Discov; 2017 Jan; 7(1):86-101. PubMed ID: 27663899
[TBL] [Abstract][Full Text] [Related]
18. Nrf2 signaling pathway: Pivotal roles in inflammation.
Ahmed SM; Luo L; Namani A; Wang XJ; Tang X
Biochim Biophys Acta Mol Basis Dis; 2017 Feb; 1863(2):585-597. PubMed ID: 27825853
[TBL] [Abstract][Full Text] [Related]
19. Sulforaphane Regulates NFE2L2/Nrf2-Dependent Xenobiotic Metabolism Phase II and Phase III Enzymes Differently in Human Colorectal Cancer and Untransformed Epithelial Colon Cells.
Lubelska K; Wiktorska K; Mielczarek L; Milczarek M; Zbroińska-Bregisz I; Chilmonczyk Z
Nutr Cancer; 2016; 68(8):1338-1348. PubMed ID: 27636860
[TBL] [Abstract][Full Text] [Related]
20. Nrf2-a Promising Therapeutic Target for Defensing Against Oxidative Stress in Stroke.
Zhang R; Xu M; Wang Y; Xie F; Zhang G; Qin X
Mol Neurobiol; 2017 Oct; 54(8):6006-6017. PubMed ID: 27696223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
